Delcath's (DCTH) Liver Cancer Device Keeps Growing, But At A Cost
On August 6, Delcath Systems (NASDAQ:DCTH) reported second-quarter results that showed the company selling more of its liver cancer treatment than ever, even as the cost of running the business climbed...





